Back
Inhibrx Vs. Seres Therapeutics Industry Stock Comparison
Sell
33
INBX
Inhibrx
Last Price:
21.20
Seasonality Move:
-22.08%
Buy
74
MCRB
Seres Therapeutics
Last Price:
6.03
Seasonality Move:
-7.11%
Sell
33
Inhibrx (INBX)
is a Sell
Is Inhibrx a Buy, Sell or Hold?
- The current Inhibrx [INBX] share price is $21.74. The Score for INBX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- INBX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Seres Therapeutics (MCRB)
is a Buy
Is Seres Therapeutics a Buy, Sell or Hold?
- The current Seres Therapeutics [MCRB] share price is $6.09. The Score for MCRB is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MCRB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MCRB Stock Price Chart
What is Seres Therapeutics's stock price today?
-
The Seres Therapeutics share price today is $6.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MCRB is experiencing slight buying pressure.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 42.45 | Sell |
| Chaikin Money Flow: | -126942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.08 - 24.12) | Sell |
| Bollinger Bands (100): | (22.9 - 29.66) | Sell |
MCRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 62.41 | Buy |
| Chaikin Money Flow: | 535989 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.06 - 5.64) | Buy |
| Bollinger Bands (100): | (5.05 - 6.95) | Buy |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.96 | Sell |
| 20-day SMA: | 23.05 | Sell |
| 50-day SMA: | 23.82 | Sell |
| 200-day SMA: | 22.46 | Sell |
| 8-day EMA: | 21.99 | Sell |
| 20-day EMA: | 22.74 | Sell |
| 50-day EMA: | 23.8 | Sell |
| 200-day EMA: | 24.06 | Sell |
MCRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.6 | Buy |
| 20-day SMA: | 5.4 | Buy |
| 50-day SMA: | 5.38 | Buy |
| 200-day SMA: | 5.51 | Buy |
| 8-day EMA: | 5.65 | Buy |
| 20-day EMA: | 5.5 | Buy |
| 50-day EMA: | 5.51 | Buy |
| 200-day EMA: | 6.01 | Buy |
Inhibrx Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.07 per share.
Seres Therapeutics Earnings Growth & MCRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.99 per share, and a decrease next year of $0.65 per share.
Inhibrx Technical Analysis
| Mar-8 | Mar-9 | Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Seres Therapeutics Technical Analysis
| Mar-8 | Mar-9 | Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||